GRX-MCiPS4F-A2-NEO	
    			    			
                GENYOi006-A-2            
            
        General
| Cell Line | |
| hPSCreg name | GENYOi006-A-2 | 
| Cite as: | GENYOi006-A-2 (RRID:CVCL_YN84) | 
| Alternative name(s) | 
	GRX-MCiPS4F-A2-NEO	 | 
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | GENYOi006-A (GRX-MCiPS4F-A2) GENYOi006-A-1 (GRX-MCiPS4F-A2-ETO2-GLIS2) | 
| Last update | 15th June 2020 | 
| User feedback | |
| Provider | |
| Generator | Centre for Genomics and Oncological Research (GENYO) | 
| Derivation country | Spain | 
| External Databases | |
| BioSamples | SAMEA6438548 | 
| Cellosaurus | CVCL_YN84 | 
| Wikidata | Q93560865 | 
| General Information | |
| * Is the cell line readily obtainable for third parties? | No | 
| Subclone of | |
Donor Information
| General Donor Information | |
| Sex | male | 
| Ethnicity | Spaniard Caucasian | 
| Phenotype and Disease related information (Donor) | |
| Diseases | No disease was diagnosed. | 
| Disease associated phenotypes | no phenotypes | 
| Karyotyping (Donor) | |
| Has the donor karyotype been analysed? | Unknown | 
| Other Genotyping (Donor) | |
| Is there genome-wide genotyping or functional data available? | No | 
| External Databases (Donor) | |
| BioSamples | SAMEA6438546 | 
Ethics
Also have a look at the ethics information for the parental line
        				
		
			GENYOi006-A		
        				.
        			        
        			        			        			        			| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | 
hIPSC Derivation
| General | |
| The source cell information can be found in the parental cell line
						GENYOi006-A. | |
| Reprogramming method | |
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Is reprogramming vector detectable? | No | 
| Methods used | 
	RT-PCR	 | 
| Vector free reprogramming | |
| Other | |
| Derived under xeno-free conditions | No | 
| Derived under GMP? | No | 
| Available as clinical grade? | No | 
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Feeder cells | No | 
| Passage method | Enzyme-free cell dissociation 
											EDTA										 | 
| O2 Concentration | 20 % | 
| CO2 Concentration | 5 % | 
| Medium | Essential 8™ | 
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes | 
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No | 
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes | 
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| Alkaline Phosphatase | Yes |  | ||||
| NANOG | Yes |  | ||||
| POU5F1 (OCT-4) | Yes |  |  | |||
| SOX2 | Yes |  | ||||
| SSEA-3 | Yes |  | ||||
| SSEA-4 | Yes |  | ||||
| TRA 1-60 | Yes |  | ||||
| TRA 1-81 | Yes |  | ||||
| ZFP42 (REX-1) | Yes |  | 
Differentiation Potency
| Microbiology / Virus Screening | |
| Mycoplasma | Negative | 
Genotyping
| Karyotyping (Cell Line) | |
| Has the cell line karyotype been analysed? | Yes 
												46, XY
											 
											Karyotyping method:
											G-Banding											
																						 | 
| Other Genotyping (Cell Line) | |
Genetic Modification
| Genetic modifications not related to a disease |  | 

Login to share your feedback, experiences or results with the research community.